02:10 PM EDT, 08/07/2024 (MT Newswires) -- G1 Therapeutics ( GTHX ) has agreed to be acquired by Pharmacosmos unit Pharmacosmos Therapeutics for $7.15 per share in cash for a total equity value of about $405 million, the companies said Wednesday.

Shares advanced 66% as intraday trading volume rose to over 31.8 million versus the stock's daily average of about 1.65 million.

Upstart (UPST) reported late Tuesday Q2 results that surpassed market expectations and provided Q3 revenue guidance above the consensus estimate.

Shares surged 43% as intraday trading volume catapulted to more than 37.1 million from a daily average of about 5.43 million.

Lumen Technologies ( LUMN ) shares soared after upgrades from analysts, likely driven by the company's decision to raise its fiscal 2024 free cash flow guidance.

Goldman Sachs upgraded the company's stock to neutral from sell and increased its price target to $4 from $1. JPMorgan also upgraded Lumen to neutral from underweight.

Shares of Lumen jumped 30% as intraday trading volume soared to over 218.3 million from a daily average of about 22.3 million.

Price: 7.06, Change: +2.81, Percent Change: +66.12